Functional Characterization of CLPTM1L as a Lung Cancer Risk Candidate Gene in the 5p15.33 Locus
Open Access
- 4 June 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (6), e36116
- https://doi.org/10.1371/journal.pone.0036116
Abstract
Cleft Lip and Palate Transmembrane Protein 1-Like (CLPTM1L), resides in a region of chromosome 5 for which copy number gain has been found to be the most frequent genetic event in the early stages of non-small cell lung cancer (NSCLC). This locus has been found by multiple genome wide association studies to be associated with lung cancer in both smokers and non-smokers. CLPTM1L has been identified as an overexpressed protein in human ovarian tumor cell lines that are resistant to cisplatin, which is the only insight thus far into the function of CLPTM1L. Here we find CLPTM1L expression to be increased in lung adenocarcinomas compared to matched normal lung tissues and in lung tumor cell lines by mechanisms not exclusive to copy number gain. Upon loss of CLPTM1L accumulation in lung tumor cells, cisplatin and camptothecin induced apoptosis were increased in direct proportion to the level of CLPTM1L knockdown. Bcl-xL accumulation was significantly decreased upon loss of CLPTM1L. Expression of exogenous Bcl-xL abolished sensitization to apoptotic killing with CLPTM1L knockdown. These results demonstrate that CLPTM1L, an overexpressed protein in lung tumor cells, protects from genotoxic stress induced apoptosis through regulation of Bcl-xL. Thus, this study implicates anti-apoptotic CLPTM1L function as a potential mechanism of susceptibility to lung tumorigenesis and resistance to chemotherapy.Keywords
This publication has 30 references indexed in Scilit:
- Amplified Genes May Be Overexpressed, Unchanged, or Downregulated in Cervical Cancer Cell LinesPLOS ONE, 2012
- Evaluation of Candidate Stromal Epithelial Cross-Talk Genes Identifies Association between Risk of Serous Ovarian Cancer and TERT, a Cancer Susceptibility “Hot-Spot”PLoS Genetics, 2010
- The association of telomere length and genetic variation in telomere biology genesaHuman Mutation, 2010
- Gene Expression Profile Associated with Response to Doxorubicin-Based Therapy in Breast CancerClinical Cancer Research, 2005
- Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cellsOncology Reports, 2005
- A Novel Gene, CRR9, Which Was Up-Regulated in CDDP-Resistant Ovarian Tumor Cell Line, Was Associated with ApoptosisBiochemical and Biophysical Research Communications, 2001
- Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuliOncogene, 1999
- Characterization of a Novel Gene Disrupted by a Balanced Chromosomal Translocation t(2;19)(q11.2;q13.3) in a Family with Cleft Lip and PalateGenomics, 1998
- Bcl-XL protects cancer cells from p53-mediated apoptosis.1995
- Multiple Bcl-2 family members demonstrate selective dimerizations with Bax.Proceedings of the National Academy of Sciences of the United States of America, 1995